Milan Franek

Milan Franek

Auto-generated profile, based on publicly available information

Milan Franek

Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2006 in Analytical Chemistry
Verified
Journal Article
Closed access
MFMilan Franek
Milan Franek
IDIva Diblikova
Iva Diblikova
ICIvo Cernoch
Ivo Cernoch
MVMaria Vass
Maria Vass
KHKarel Hruska
Karel Hruska


25 September 2001 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
MFM. Fránek
M. Fránek
JZJ. Zeravík
J. Zeravík
SES. Eremin
S. Eremin
JYJ. Yakovleva
J. Yakovleva
MBM. Badea
M. Badea
JEJ. Emnéus
J. Emnéus

1 November 2000 in Electroanalysis
Verified
Journal Article
Closed access
PDF file
SLSerena Laschi
Serena Laschi
MFMilan Fránek
Milan Fránek
MMMarco Mascini
Marco Mascini

1 September 2015 in Journal of Chromatography B
Verified
Journal Article
Open access
RWRoksana Wierzbicka
Roksana Wierzbicka
HWHuaxing Wu
Huaxing Wu
MFMilan Franek
Milan Franek
AKAfaf Kamal-Eldin
Afaf Kamal-Eldin
RLRikard Landberg
Rikard Landberg
High throughput GC-MS methods for quantification of alkylresorcinols (AR), biomarkers of whole grain wheat and rye intake, in plasma and adipose tissue and their metabolites in urine were developed and optimised. Alkylresorcinols in plasma (200μL) and adipose tissues (10-50mg) were extracted with diethyl ether, whereas main AR metabolites such as DHBA and DHPPA and newly identified metabolites in urine (50μL) were extracted with ethyl acetate after enzymatic deconjugation. All extracts were purified on OASIS-MAX solid phase extraction cartridges. Plasma and adipose tissue sample extracts were then derivatised with trifluoroacetic anhydride and reconstituted in undecane, whereas AR metabolites in urine samples were derivatised with BSTFA+TMCS (99:1, v/v, 100μL). Prepared samples were quantified by GC-MS (EI-SIM). Analysis of all compounds in the different matrices showed good selectivity, sensitivity, linearity, precision (<15% within and between batches), adequate recovery (75-108%), and short total run time (10-12min). The methods developed are applicable to large-scale sample sets such as epidemiological studies.

1 August 2008 in Food Additives & Contaminants: Part A
Verified
Journal Article
Closed access
MVMaria Vass
Maria Vass
IDIva Diblikova
Iva Diblikova
EKEloise Kok
Eloise Kok
KSKamil Stastny
Kamil Stastny
KFKarla Frgalova
Karla Frgalova
MFMilan Franek
Milan Franek
An enzyme-linked immunosorbent assay (ELISA) method is described for the semi-quantitative determination of semicarbazide (SEM), the marker residue for the banned nitrofuran drug, nitrofurazone, in chicken eggs. The sample homogenate is subjected to acid hydrolysis and derivatisation with o-nitrobenzaldehyde, followed by ethyl acetate/hexane extraction and detection by ELISA. The ELISA procedure has been validated using 0.3, 1.0 and 3 µg kg−1 of SEM in fortified samples. Detection capability (CCß) was based on the acceptance of 5% false compliant results for a given concentration level according to Commission Decision 2002/657/EC and was determined to be 0.3 µg kg−1 with a respective limit of detection of 0.13 µg kg−1. A validated LC–MS/MS method was used for the analysis of incurred egg samples and the results compared with ELISA. A good correlation between the results obtained from ELISA and LC–MS/MS within the concentration range 0.12–20.3 µg kg−1 was observed in samples collected from chickens fed with a medicated ration of nitrofurazone (r = 0.992, n = 14). Validated ELISA enabled reliable monitoring of SEM levels in eggs collected from incurred chickens over a 90-day period.